Abstract:Objective: To elucidate whether DNA aneuploidy was an independent discriminator for carcinoma within oral potentially malignant disorders (OPMDs), and further establish and validate a risk model based on DNA aneuploidy for the detection of oral cancer. Methods: A total of 810 consecutive patients with OPMD were prospectively enrolled from March 2013 to December 2018, and divided into a training set (n = 608) and a test set (n = 202). Brushing and biopsy samples from each patient were processed by DNA- DNA image cytometry and histopathological examination, respectively. Results: DNA aneuploidy of an outside DNA index ≥ 3.5 in OPMD was an independent marker strongly associated with malignant risk [adjusted odds ratio: 13.04; 95% confidence interval (CI): 5.46–31.14]. In the training and test sets, the area under the curve (AUC) was 0.87 (95% CI: 0.82–0.91) and 0.77 (95% CI: 0.57–0.97), respectively, for detecting carcinoma in OPMD patients. The independent risk factors of lateral/ventral tongue and non-homogenous type combined with a risk model built with a multivariate logistic regression revealed a more favorable diagnostic efficacy associated with the training set (AUC: 0.93; 95% CI: 0.91–0.96) and test set (AUC: 0.94; 95% CI: 0.90–0.98). The sensitivity and specificity of carcinoma detection within OPMD was improved to 100% and 88.1%, respectively. Conclusions: This large-scale diagnostic study established a risk model based on DNA aneuploidy that consisted of a noninvasive strategy with lateral/ventral tongue and non-homogenous features. The results showed favorable diagnostic efficacy for detecting carcinoma within OPMD, irrespective of the clinical and pathological diagnoses of OPMD. Multicenter validation and longitudinal studies are warranted to evaluate community practices and clinical applications.

Research Progress of Quantitative DNA Analysis in Oral Carcinoma and Precancerous Lesions

Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine

Dna Content Status Using Brush Biopsy with Image Cytometry Correlated with Staging of Oral Leukoplakia: A Preliminary Study

Quantification of Microvascular Dentsity and Cell Nuclear DNA Content in Laryngeal Cancer

Quantitative DNA Analysis in Diagnosis of Benign and Malignant Breast Masses

Current Evidence on DNA Aneuploidy Cytology in Noninvasive Detection of Oral Cancer

Quantitative analysis of cellular DNA content of colorectal adenoma tissue

Cytological Study of DNA Content and Nuclear Morphometric Analysis for Aid in the Diagnosis of High-Grade Dysplasia Within Oral Leukoplakia.

Dna Content Abnormality In Oral Submucous Fibrosis Concomitant Leukoplakia: A Preliminary Evaluation Of The Diagnostic And Clinical Implications

Development and Validation of a Risk Model for Noninvasive Detection of Cancer in Oral Potentially Malignant Disorders Using DNA Image Cytometry

Oral cancer detection and progression prediction using noninvasive cytology‐based DNA ploidy approach

[Relative Quantification of Cytokeratin 19 Transcription in Oral Squamous Cell Carcinoma Tissues by Fluorescent Quantitive Real-Time RT-PCR].

Preliminary Analysis of Gene Expression Profiles in Oral Cancer with Microarray Technique

Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis

[Quantitative Study of the Cellular Nuclear DNA Contents in Odontogenic Cysts and Ameloblastoma].

Application of serum DNA quantification in the diagnosis of epithelial ovarian cancer

A comparative study of liquid based cytology examination and DNA quantitative analysis in 879 women

Focus on DNA-aneuploidy cytology relationship with dysplasia and clinical features in OPMDs

DNA Ploidy Property in Cancer Nests and Tissue of Incisional Edge of Oral Squamous Cell Carcinomas.

The study of relation of the oral cancer chemotherapy and flow cytome try

Quantitative Proteomic Analysis of Microdissected Oral Epithelium for Cancer Biomarker Discovery